Related Experiment Videos
Insulinotropic action of glutamic acid dimethyl ester
A Sener1, I Conget, J Rasschaert
1Laboratory of Experimental Medicine, Brussels Free University, Belgium.
The American Journal of Physiology
|October 1, 1994
Summary
Glutamic acid dimethyl ester (GME) enhances insulin release by stimulating pancreatic beta-cells. This compound may offer a novel approach to address beta-cell dysfunction in diabetes models.
Area of Science:
- Endocrinology
- Metabolism
- Cell Biology
Background:
- Pancreatic beta-cell dysfunction is central to non-insulin-dependent diabetes mellitus (NIDDM).
- Identifying novel compounds that can enhance insulin secretion is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of glutamic acid dimethyl ester (GME) on insulin release from pancreatic islets.
- To elucidate the mechanisms underlying GME-induced insulin secretion.
Main Methods:
- Incubation of pancreatic islets with GME and various secretagogues (D-glucose, L-leucine, etc.).
- Measurement of insulin release, ion fluxes (86Rb, 45Ca), oxygen consumption, and substrate metabolism.
- Isotopic labeling studies to trace GME metabolism.
Main Results:
- GME potentiated glucose- and amino acid-stimulated insulin release, shifting the dose-response curve leftward.
- GME unmasked glibenclamide's insulinotropic effect in the absence of glucose.
- GME altered ion fluxes and was metabolized to L-glutamate and other metabolites.
- GME modulated oxygen consumption by balancing its own oxidation and sparing endogenous fuels.
Conclusions:
- GME effectively enhances insulin secretion by acting on pancreatic beta-cells.
- GME metabolism leads to L-glutamate and influences cellular energy pathways.
- GME shows potential as a tool to overcome beta-cell defects in NIDDM models by bypassing impaired glucose metabolism.